BioNTech

Latest

BioNTech, CureVac, Moderna: mRNA technology – potential to revolutionize medicine – Commerzbank column

The new “mRNA vaccines” are not only considered a major milestone in the fight against the corona pandemic – the…

Read More »
Latest

BioNTech: A lot of good news

There has been tremendous progress with BioNTech and Pfizer’s corona vaccination. Until now, the necessary storage at -70 degrees was…

Read More »
Latest

BioNTech and Pfizer: Difficulties in delivering the COVID-19 vaccine looming

BioNTech’s partner Pfizer has apparently admitted that there will be bottlenecks in deliveries of the COVID-19 vaccine in the next…

Read More »
Latest

BioNTech share: The chances have not diminished

Yesterday’s range of fluctuation for BioNTech shares on NASDAQ was not exactly small, with prices between $ 101.01 and $…

Read More »
Latest

BioNTech now plans to produce 2 billion doses of the COVID-19 vaccine in 2021 – plans raised

BioNTech and partner Pfizer want to produce significantly more doses of their COVID-19 vaccine BNT162b2, which is now approved and…

Read More »
Latest

BioNTech share: That looks good!

In the last few days we have repeatedly pointed out the opportunities for a turnaround in the BioNTech share following…

Read More »
Latest

BioNTech share: will that be the big surprise? – Chart analysis

Will the BioNTech share make the big upward swing? Most recently, the biotech share lost ground after a bull run…

Read More »
Latest

BioNTech share: first bull market, then panic – exaggerations go on both sides

The second half of December was a single disappointment for many BioNTech share investors. From an all-time high of $…

Read More »
Latest

BioNTech shares after the fall: a spark of hope for the share price

Did the bears overdo it yesterday on the BioNTech share? The share price of the favorite investor and developer of…

Read More »
Latest

BioNTech share: The crash of the investor’s favorite could go on

With share prices between 96.64 dollars and 99.89 dollars, the BioNTech share was unable to set any new technical accents…

Read More »
Back to top button
Close
Close